First Time Loading...

Aldeyra Therapeutics Inc
NASDAQ:ALDX

Watchlist Manager
Aldeyra Therapeutics Inc Logo
Aldeyra Therapeutics Inc
NASDAQ:ALDX
Watchlist
Price: 3.94 USD -2.23% Market Closed
Updated: May 22, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

141.3m
-5%
Assets
Growth Rates:
1 Year
-16%
3 Years
-4%
5 Years
+60%
7 Years
+349%
10 Years
+4 772%
27.9m
-2%
Liabilities
Growth Rates:
1 Year
-10%
3 Years
+32%
5 Years
+190%
7 Years
+697%
10 Years
+597%
113.4m
-5%
Equity
Growth Rates:
1 Year
-17%
3 Years
-10%
5 Years
+44%
7 Years
+305%
10 Years
-

Balance Sheet Decomposition
Aldeyra Therapeutics Inc

141.3m
Assets
27.9m
Liabilities
141.3m
Assets
27.9m
Liabilities
Current Assets 140.8m
Cash & Short-Term Investments 133m
Other Current Assets 7.8m
Non-Current Assets 455.9k
PP&E 456k
Other Non-Current Assets -10
Current Liabilities 21.7m
Accounts Payable 280.3k
Accrued Liabilities 6.2m
Other Current Liabilities 15.2m
Non-Current Liabilities 6.2m
Other Non-Current Liabilities 6.2m

Balance Sheet
Aldeyra Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
9
15
12
20
47
45
78
230
145
143
Cash
0
0
0
0
2
15
24
100
135
129
Cash Equivalents
9
15
12
20
45
29
54
129
9
14
Short-Term Investments
0
13
13
23
46
29
0
0
30
0
Other Current Assets
0
1
0
1
1
2
5
3
7
5
Total Current Assets
9
28
25
44
95
75
83
233
181
148
PP&E Net
0
0
0
0
0
0
0
0
0
1
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
9
N/A
28
+220%
25
-11%
44
+75%
95
+115%
76
-21%
83
+10%
233
+179%
181
-22%
148
-18%
Liabilities
Accounts Payable
0
1
0
1
3
1
0
1
0
1
Accrued Liabilities
1
1
2
2
5
12
8
11
14
6
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
4
0
1
15
Total Current Liabilities
1
2
2
3
9
13
12
12
15
22
Long-Term Debt
1
1
1
1
0
15
11
16
15
0
Other Liabilities
0
0
0
0
0
0
0
0
0
6
Total Liabilities
3
N/A
3
+32%
4
+6%
5
+31%
9
+85%
27
+222%
24
-13%
27
+15%
30
+11%
29
-6%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
47
59
77
100
139
199
237
295
357
394
Additional Paid In Capital
53
84
99
139
225
247
296
500
508
514
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
6
N/A
25
+295%
22
-13%
40
+83%
87
+119%
48
-44%
60
+24%
206
+246%
151
-27%
120
-21%
Total Liabilities & Equity
9
N/A
28
+220%
25
-11%
44
+75%
95
+115%
76
-21%
83
+10%
233
+179%
181
-22%
148
-18%
Shares Outstanding
Common Shares Outstanding
6
10
13
19
26
29
39
58
59
59

See Also

Summary
ALDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALDX stock valuation using valuation multiples.
Wall Street Estimates
ALDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.